Bare-metal, drug-eluting, and bioresorbable stents in context

Malcolm R. Bell, M.D., Rajiv Gulati, M.D., Ph.D., and Gurpreet S. Sandhu, M.D., Ph.D., specialists in Cardiovascular Diseases at Mayo Clinic's campus in Rochester, Minnesota, discuss the use of bare-metal, drug-eluting, and bioresorbable stents, including findings from the Norwegian Coronary Stent (NORSTENT) Trial findings.

This video was first shown on Medscape Cardiology.


March 1, 2017

Created by

Mayo Clinic